Antibody discovered by RQ Bio enters pivotal research phase
AstraZeneca trial will study activity of AZD5156 which includes monoclonal antibody discovered by RQ Bio
Read More
Tag: RQ Bio
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
